Form 8-K - Current report:
SEC Accession No. 0001213900-25-030320
Filing Date
2025-04-09
Accepted
2025-04-09 16:30:07
Documents
14
Period of Report
2025-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237436-8k_adaptin.htm   iXBRL 8-K 23826
2 PRESS RELEASE, DATED APRIL 7, 2025 ea023743601ex99-1_adaptin.htm EX-99.1 13546
  Complete submission text file 0001213900-25-030320.txt   214560

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cik0001938571-20250407.xsd EX-101.SCH 3080
4 XBRL LABEL FILE cik0001938571-20250407_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE cik0001938571-20250407_pre.xml EX-101.PRE 22393
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0237436-8k_adaptin_htm.xml XML 3583
Mailing Address 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC 28277
Business Address 3540 TORINGDON WAY SUITE 200, #250 CHARLOTTE NC 28277 (888) 609-1498
ADAPTIN BIO, INC. (Filer) CIK: 0001938571 (see all company filings)

EIN.: 881566415 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56583 | Film No.: 25825551
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)